Induction	O
of	O
Bcl-x	B-protein
(	I-protein
L	I-protein
)	I-protein
expression	O
by	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
1	I-protein
Tax	I-protein
through	O
NF-kappaB	B-protein
in	O
apoptosis-resistant	B-cell_line
T-cell	I-cell_line
transfectants	I-cell_line
with	O
Tax	B-protein
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
Tax	B-protein
is	O
thought	O
to	O
play	O
a	O
pivotal	O
role	O
in	O
immortalization	O
of	O
T	B-cell_type
cells	I-cell_type
.	O

We	O
have	O
recently	O
shown	O
that	O
the	O
expression	O
of	O
Tax	B-protein
protected	O
the	O
mouse	B-cell_line
T-cell	I-cell_line
line	I-cell_line
CTLL-2	I-cell_line
against	O
apoptosis	O
induced	O
by	O
interleukin-2	B-protein
(	O
IL-2	B-protein
)	O
deprivation	O
and	O
converted	O
its	O
growth	O
from	O
being	O
IL-2	B-protein
dependent	O
to	O
being	O
IL-2	B-protein
independent	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
constitutive	O
expression	O
of	O
bcl-xl	B-protein
but	O
not	O
bcl-2	B-protein
,	O
bcl-xs	B-protein
,	O
bak	B-protein
,	O
bad	B-protein
,	O
or	O
bax	B-protein
was	O
associated	O
with	O
apoptosis	O
resistance	O
after	O
IL-2	B-protein
deprivation	O
in	O
CTLL-2	B-cell_line
cells	I-cell_line
that	O
expressed	O
Tax	B-protein
.	O

Transient-transfection	O
assays	O
showed	O
that	O
bcl-x	B-DNA
promoter	I-DNA
was	O
transactivated	O
by	O
wild-type	B-protein
Tax	I-protein
.	O

Similar	O
effects	O
were	O
observed	O
in	O
mutant	O
Tax	B-protein
retaining	O
transactivating	O
ability	O
through	O
NF-kappaB	B-protein
.	O

Deletion	O
or	O
substitution	O
of	O
a	O
putative	B-protein
NF-kappaB	I-protein
binding	I-protein
site	I-protein
identified	O
in	O
the	O
bcl-x	B-DNA
promoter	I-DNA
significantly	O
decreased	O
Tax	B-protein
-induced	O
transactivation	O
.	O

This	O
NF-kappaB-like	B-DNA
element	I-DNA
was	O
able	O
to	O
form	O
a	O
complex	O
with	O
NF-kappaB	B-protein
family	I-protein
proteins	I-protein
in	O
vitro	O
.	O

Furthermore	O
,	O
Tax	B-protein
-induced	O
transactivation	O
of	O
the	O
bcl-x	B-DNA
promoter	I-DNA
was	O
also	O
diminished	O
by	O
the	O
mutant	B-protein
IkappaBalpha	I-protein
,	O
which	O
specifically	O
inhibits	O
NF-kappaB	B-protein
activity	O
.	O

Our	O
findings	O
suggest	O
that	O
constitutive	O
expression	O
of	O
Bcl-x	B-protein
(	I-protein
L	I-protein
)	I-protein
induced	O
by	O
Tax	B-protein
through	O
the	O
NF-kappaB	B-protein
pathway	O
contributes	O
to	O
the	O
inhibition	O
of	O
apoptosis	O
in	O
CTLL-2	B-cell_line
cells	I-cell_line
after	O
IL-2	B-protein
deprivation	O
.	O

JouRrNaAL	NULL
or	NULL
VirRoLoGY	NULL
,	NULL
Oct.	NULL
1999	NULL
,	NULL
p.	NULL
7981-7987	NULL
0022-538	NULL
X/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

73	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Induction	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
Expression	NULL
by	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
through	NULL
NF-KB	NULL
in	NULL
Apoptosis-Resistant	NULL
T-Cell	NULL
Transfectants	NULL
with	NULL
Tax	NULL
TOMONORI	NULL
TSUKAHARA	NULL
,	NULL
*	NULL
MARI	NULL
KANNAGLI	NULL
,	NULL
~*	NULL
TAKASHI	NULL
OHASHI	NULL
,	NULL
'*	NULL
HIROTOMO	NULL
KATO	NULL
,	NULL
``	NULL
MASAAKI	NULL
ARAL*	NULL
GABRIEL	NULL
NUNEZ	NULL
,	NULL
*	NULL
YOUICHI	NULL
IWANAGA	NULL
,	NULL
*	NULL
NAOKI	NULL
YAMAMOTO	NULL
,	NULL
``	NULL
KIYOSHI	NULL
OHTANI	NULL
,	NULL
*	NULL
MASATAKA	NULL
NAKAMURA	NULL
,	NULL
``	NULL
anp	NULL
MASAHIRO	NULL
FUJII®	NULL
Department	NULL
of	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
``	NULL
Medical	NULL
Research	NULL
Division	NULL
,	NULL
and	NULL
Human	NULL
Gene	NULL
Sciences	NULL
Center	NULL
,	NULL
``	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
CREST	NULL
,	NULL
Japan	NULL
Science	NULL
and	NULL
Technology	NULL
Corporation	NULL
,	NULL
Saitama	NULL
332	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
Niigata	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Niigata	NULL
951	NULL
,	NULL
°	NULL
Japan	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
School	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
48109°	NULL
Received	NULL
10	NULL
February	NULL
1999/Accepted	NULL
14	NULL
June	NULL
1999	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
Tax	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
immortalization	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
Tax	NULL
protected	NULL
the	NULL
mouse	NULL
T-cell	NULL
line	NULL
CTLL-2	NULL
against	NULL
apoptosis	NULL
induced	NULL
by	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
deprivation	NULL
and	NULL
converted	NULL
its	NULL
growth	NULL
from	NULL
being	NULL
IL-2	NULL
dependent	NULL
to	NULL
being	NULL
IL-2	NULL
independent	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
constitutive	NULL
expression	NULL
of	NULL
be/-x/	NULL
but	NULL
not	NULL
bel-2	NULL
,	NULL
bel-xs	NULL
,	NULL
bak	NULL
,	NULL
bad	NULL
,	NULL
or	NULL
bax	NULL
was	NULL
associated	NULL
with	NULL
apoptosis	NULL
resistance	NULL
after	NULL
IL-2	NULL
deprivation	NULL
in	NULL
CTLL-2	NULL
cells	NULL
that	NULL
expressed	NULL
Tax	NULL
.	NULL

Transient-transfection	NULL
assays	NULL
showed	NULL
that	NULL
be/-x	NULL
promoter	NULL
was	NULL
transactivated	NULL
by	NULL
wild-type	NULL
Tax	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
mutant	NULL
Tax	NULL
retaining	NULL
transactivating	NULL
ability	NULL
through	NULL
NF-KB	NULL
.	NULL

Deletion	NULL
or	NULL
substitution	NULL
of	NULL
a	NULL
putative	NULL
NF-B	NULL
binding	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
be/-x	NULL
promoter	NULL
significantly	NULL
decreased	NULL
Tax-induced	NULL
trans-activation	NULL
.	NULL

This	NULL
NF-KB-like	NULL
element	NULL
was	NULL
able	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
NF-KB	NULL
family	NULL
proteins	NULL
in	NULL
vitro	NULL
.	NULL

Furthermore	NULL
,	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
the	NULL
be/-x	NULL
promoter	NULL
was	NULL
also	NULL
diminished	NULL
by	NULL
the	NULL
mutant	NULL
IBa	NULL
,	NULL
which	NULL
specifically	NULL
inhibits	NULL
NF-KB	NULL
activity	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
;	NULL
,	NULL
induced	NULL
by	NULL
Tax	NULL
through	NULL
the	NULL
NF-B	NULL
pathway	NULL
contributes	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
CTLL-2	NULL
cells	NULL
after	NULL
IL-2	NULL
deprivation	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
the	NULL
etio-logical	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
22	NULL
,	NULL
34	NULL
)	NULL
.	NULL

HTLV-1	NULL
encodes	NULL
a	NULL
40-kDa	NULL
regulatory	NULL
protein	NULL
,	NULL
Tax	NULL
,	NULL
that	NULL
accelerates	NULL
viral	NULL
gene	NULL
expression	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
15	NULL
,	NULL
39	NULL
,	NULL
41	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
transforming	NULL
features	NULL
of	NULL
HTLV-1	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
,	NULL
such	NULL
as	NULL
in	NULL
vitro	NULL
transformation	NULL
of	NULL
rodent	NULL
fibroblasts	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
27	NULL
,	NULL
46	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
induction	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
mesenchymal	NULL
tumors	NULL
and	NULL
leukemia	NULL
in	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
tax	NULL
gene	NULL
(	NULL
20	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Various	NULL
mechanisms	NULL
of	NULL
T-cell	NULL
leukemogenesis	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
have	NULL
been	NULL
proposed	NULL
.	NULL

Some	NULL
of	NULL
them	NULL
relate	NULL
to	NULL
the	NULL
transcriptional	NULL
activator	NULL
function	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

Tax	NULL
activates	NULL
the	NULL
transcription	NULL
of	NULL
not	NULL
only	NULL
HTLV-1	NULL
itself	NULL
but	NULL
also	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
in	NULL
trans	NULL
.	NULL

This	NULL
transactivation	NULL
by	NULL
Tax	NULL
is	NULL
mediated	NULL
through	NULL
interaction	NULL
with	NULL
transcriptional	NULL
factors	NULL
CREB	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
14	NULL
,	NULL
42-44	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
target	NULL
genes	NULL
related	NULL
to	NULL
cellular	NULL
activation	NULL
and	NULL
growth	NULL
is	NULL
enhanced	NULL
by	NULL
Tax	NULL
.	NULL

These	NULL
include	NULL
genes	NULL
for	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimu-lating	NULL
factor	NULL
,	NULL
the	NULL
«	NULL
chain	NULL
of	NULL
IL-2	NULL
receptor	NULL
,	NULL
Fra-1	NULL
,	NULL
c-Myc	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
c-Jun	NULL
(	NULL
36	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Aberrant	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
dysregulated	NULL
proliferation	NULL
of	NULL
HTLV-1-in-fected	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
support	NULL
another	NULL
hypothesis	NULL
;	NULL
that	NULL
Tax	NULL
may	NULL
induce	NULL
cell	NULL
cycle	NULL
promotion	NULL
through	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Suzuki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
45	NULL
)	NULL
demonstrated	NULL
that	NULL
Tax	NULL
binds	NULL
and	NULL
inac-tivates	NULL
p16	NULL
``	NULL
~*	NULL
``	NULL
``	NULL
,	NULL
a	NULL
negative	NULL
regulatory	NULL
molecule	NULL
of	NULL
the	NULL
cell	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Immuno-therapeutics	NULL
,	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
Medical	NULL
Research	NULL
Division	NULL
,	NULL
1-5-45	NULL
Yushima	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81	NULL
(	NULL
3	NULL
)	NULL
5803-5798	NULL
.	NULL

Fax	NULL
:	NULL
81	NULL
(	NULL
3	NULL
)	NULL
5803-0235	NULL
.	NULL

E-mail	NULL
:	NULL
kann.impt	NULL
@	NULL
med.tmd.ac.jp	NULL
.	NULL

7981	NULL
cycle	NULL
.	NULL

Tax	NULL
may	NULL
also	NULL
directly	NULL
associate	NULL
with	NULL
cyclin	NULL
D	NULL
,	NULL
which	NULL
is	NULL
important	NULL
in	NULL
cell	NULL
cycle	NULL
transition	NULL
from	NULL
G	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Tax	NULL
also	NULL
influences	NULL
cell	NULL
apoptosis	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
human	NULL
T-cell	NULL
lines	NULL
expressing	NULL
Tax	NULL
were	NULL
resistant	NULL
to	NULL
apoptosis	NULL
signals	NULL
triggered	NULL
through	NULL
Fas	NULL
receptors	NULL
(	NULL
2	NULL
,	NULL
9	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
resistance	NULL
to	NULL
apoptosis	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
tax	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Resistance	NULL
to	NULL
cell	NULL
apoptosis	NULL
is	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
of	NULL
autoim-munity	NULL
and	NULL
is	NULL
also	NULL
an	NULL
important	NULL
requirement	NULL
for	NULL
the	NULL
immortalization	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Other	NULL
investigators	NULL
,	NULL
however	NULL
,	NULL
have	NULL
reported	NULL
opposite	NULL
observations	NULL
;	NULL
Tax	NULL
induces	NULL
apoptosis	NULL
of	NULL
rat	NULL
fibroblasts	NULL
and	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
under	NULL
certain	NULL
conditions	NULL
(	NULL
7	NULL
,	NULL
53	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
mechanisms	NULL
of	NULL
the	NULL
Tax	NULL
effect	NULL
on	NULL
apoptosis	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
Tax	NULL
in	NULL
a	NULL
mouse	NULL
T-cell	NULL
line	NULL
CTLL-2	NULL
converted	NULL
its	NULL
growth	NULL
from	NULL
being	NULL
IL-2	NULL
dependent	NULL
to	NULL
being	NULL
IL-2	NULL
independent	NULL
.	NULL

Not	NULL
only	NULL
promotion	NULL
of	NULL
cell	NULL
cycle	NULL
but	NULL
also	NULL
prevention	NULL
of	NULL
apoptosis	NULL
occurred	NULL
in	NULL
these	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
Tax	NULL
prevents	NULL
apoptosis	NULL
.	NULL

We	NULL
demonstrated	NULL
(	NULL
i	NULL
)	NULL
that	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
one	NULL
of	NULL
the	NULL
molecules	NULL
protecting	NULL
cells	NULL
against	NULL
apoptosis	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
resistance	NULL
of	NULL
CTLL-2/Tax	NULL
transfectants	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
Tax	NULL
transactivates	NULL
bel-xl	NULL
through	NULL
the	NULL
NF-kB	NULL
pathway	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
report	NULL
that	NULL
indicates	NULL
the	NULL
involvement	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
in	NULL
HTLV-1	NULL
Tax-induced	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Plasmids	NULL
containing	NULL
wild-type	NULL
tax	NULL
(	NULL
pBMT-2Tax	NULL
)	NULL
,	NULL
mutant	NULL
tax	NULL
genes	NULL
(	NULL
pBTax703	NULL
and	NULL
pBTaxM22	NULL
)	NULL
driven	NULL
by	NULL
a	NULL
B-actin	NULL
promoter	NULL
,	NULL
and	NULL
its	NULL
control	NULL
plasmid	NULL
(	NULL
pHBAPr-1-neo	NULL
)	NULL
were	NULL
used	NULL
(	NULL
21	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Wild-type	NULL
Tax	NULL
encoded	NULL
in	NULL
pBMT-2Tax	NULL
is	NULL
effective	NULL
in	NULL
the	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
CArG	NULL
,	NULL
and	NULL
CRE	NULL
sites	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
7982	NULL
TSUKAHARA	NULL
ET	NULL
AL	NULL
.	NULL

Tax	NULL
mutant	NULL
encoded	NULL
by	NULL
pBTax703	NULL
can	NULL
activate	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
but	NULL
not	NULL
the	NULL
CArG	NULL
or	NULL
the	NULL
CRE	NULL
site	NULL
,	NULL
while	NULL
the	NULL
Tax	NULL
mutant	NULL
encoded	NULL
by	NULL
pBTaxM22	NULL
can	NULL
activate	NULL
the	NULL
CArG	NULL
and	NULL
CRE	NULL
site	NULL
but	NULL
hardly	NULL
the	NULL
NF-B	NULL
site	NULL
(	NULL
40	NULL
,	NULL
44	NULL
)	NULL
.	NULL

We	NULL
also	NULL
used	NULL
the	NULL
mouse	NULL
bel-x	NULL
promoter-driven	NULL
luciferase	NULL
(	NULL
Luc	NULL
)	NULL
reporter	NULL
plasmid	NULL
pGL2-3.2	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
3.2-kbp	NULL
fragment	NULL
upstream	NULL
of	NULL
the	NULL
bei-x	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

pGL2	NULL
(	NULL
1160	NULL
)	NULL
,	NULL
pGL2	NULL
(	NULL
848	NULL
)	NULL
,	NULL
pGL2	NULL
(	NULL
822	NULL
)	NULL
,	NULL
and	NULL
pGL2	NULL
(	NULL
631	NULL
)	NULL
were	NULL
newly	NULL
generated	NULL
by	NULL
insertion	NULL
of	NULL
DNA	NULL
fragments	NULL
of	NULL
the	NULL
bel-x	NULL
promoter	NULL
at	NULL
the	NULL
base	NULL
positions	NULL
of	NULL
-1160	NULL
to	NULL
-75	NULL
,	NULL
-848	NULL
to	NULL
-75	NULL
,	NULL
-822	NULL
to	NULL
-75	NULL
,	NULL
and	NULL
-631	NULL
to	NULL
-75	NULL
from	NULL
the	NULL
translation	NULL
initiation	NULL
ATG	NULL
of	NULL
the	NULL
bel-x	NULL
gene	NULL
,	NULL
respectively	NULL
,	NULL
into	NULL
the	NULL
basic	NULL
pGL2	NULL
vector	NULL
containing	NULL
a	NULL
Luc	NULL
reporter	NULL
gene	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

These	NULL
DNA	NULL
fragments	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
DNA	NULL
templates	NULL
extracted	NULL
from	NULL
CTLL-2	NULL
cells	NULL
and	NULL
four	NULL
sense	NULL
primers	NULL
,	NULL
(	NULL
5'-CCGCTCGAGGAGGTCTCCACTGTGGGAGC-3	NULL
'	NULL
,	NULL
5	NULL
``	NULL
-CCGCTCGAGGGAA	NULL
GTCCCTTTAGGGTTTC-3	NULL
'	NULL
,	NULL
5-CTCATCTAGGGCTGGTACIT-3	NULL
'	NULL
,	NULL
and	NULL
5'-C	NULL
CGCTCGAGTGGTCGATGGAGGAACCAGG-3	NULL
'	NULL
)	NULL
and	NULL
one	NULL
antisense	NULL
primer	NULL
(	NULL
5'-GAAGATCTAGCGATTCTCTTCCAGGATC-3	NULL
'	NULL
)	NULL
.	NULL

pGL	NULL
«	NULL
BM	NULL
is	NULL
a	NULL
mutant	NULL
of	NULL
pGL2	NULL
(	NULL
848	NULL
)	NULL
,	NULL
carrying	NULL
CC-to-GG	NULL
mutations	NULL
at	NULL
positions	NULL
of	NULL
-841	NULL
and	NULL
-840	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
by	NULL
using	NULL
primers	NULL
with	NULL
the	NULL
mutation	NULL
.	NULL

Plasmid	NULL
integrity	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Another	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
,	NULL
WT-Luc	NULL
,	NULL
containing	NULL
five	NULL
tandem	NULL
repeats	NULL
of	NULL
21-bp	NULL
Tax-inducible	NULL
CREs	NULL
of	NULL
HTLV-1	NULL
LTR	NULL
originated	NULL
from	NULL
21WT-CAT	NULL
(	NULL
16	NULL
)	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
J.	NULL
Fujisawa	NULL
(	NULL
Kansai	NULL
Medical	NULL
University	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

peDNA3-IxBaM	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
an	NULL
IxBoM-coding	NULL
region	NULL
in	NULL
pBlue-script	NULL
SK	NULL
(	NULL
-	NULL
)	NULL
-I	NULL
«	NULL
xBa	NULL
$	NULL
32A/5836A	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
J.	NULL
Inoue	NULL
(	NULL
Tokyo	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
into	NULL
pcDNA3	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
Calif.	NULL
)	NULL
with	NULL
the	NULL
cytomega-lovirus	NULL
promoter	NULL
.	NULL

pSV-B-Galactosidase	NULL
Vector	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
also	NULL
used	NULL
.	NULL

Cell	NULL
lines	NULL
and	NULL
transfections	NULL
.	NULL

The	NULL
mouse	NULL
IL-2-dependent	NULL
T-cell	NULL
line	NULL
CTLL-2	NULL
(	NULL
18	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
(	NULL
RPMI-10	NULL
%	NULL
FCS	NULL
)	NULL
,	NULL
50	NULL
M	NULL
2-mercaptocethanol	NULL
and	NULL
1	NULL
nM	NULL
human	NULL
recombinant	NULL
IL-2	NULL
(	NULL
brIL-2	NULL
;	NULL
Ajinomoto	NULL
,	NULL
Yokohama	NULL
,	NULL
Japan	NULL
)	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
CTLL-2	NULL
cell	NULL
clones	NULL
permanently	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutant	NULL
HTLV-I	NULL
Tax	NULL
were	NULL
established	NULL
by	NULL
neomycin-selection	NULL
after	NULL
gene	NULL
transfection	NULL
as	NULL
described	NULL
below	NULL
.	NULL

CTLL-2	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
0.7	NULL
ml	NULL
of	NULL
FCS-free	NULL
RPMI	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
Tax	NULL
expression	NULL
plasmids	NULL
and	NULL
electroporated	NULL
by	NULL
use	NULL
of	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
at	NULL
320	NULL
V	NULL
and	NULL
950	NULL
mF	NULL
.	NULL

Then	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
of	NULL
RPMI-10	NULL
%	NULL
FCS	NULL
and	NULL
1	NULL
nM	NULL
hrIL-2	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
24-well	NULL
plates	NULL
in	NULL
G418-containing	NULL
medium	NULL
(	NULL
0.4	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
3	NULL
weeks	NULL
.	NULL

Wells	NULL
were	NULL
screened	NULL
for	NULL
Tax	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
and	NULL
cells	NULL
in	NULL
the	NULL
wells	NULL
positive	NULL
for	NULL
Tax	NULL
were	NULL
further	NULL
cloned	NULL
by	NULL
the	NULL
limiting-dilution	NULL
method	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
used	NULL
two	NULL
or	NULL
three	NULL
randomly	NULL
selected	NULL
clones	NULL
for	NULL
each	NULL
group	NULL
of	NULL
CTLL-2/Tax	NULL
transfectants	NULL
.	NULL

We	NULL
also	NULL
used	NULL
an	NULL
IL-2-independent	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
which	NULL
originated	NULL
from	NULL
human	NULL
acute	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

Expressions	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
Bcl-x	NULL
;	NULL
,	NULL
and	NULL
«	NULL
-tubulin	NULL
in	NULL
CTLL-2	NULL
cell	NULL
clones	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cell	NULL
lysates	NULL
prepared	NULL
from	NULL
CTLL-2	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
under	NULL
reduced	NULL
conditions	NULL
on	NULL
a	NULL
discontinuous	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
in	NULL
the	NULL
gel	NULL
were	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
a	NULL
human	NULL
serum	NULL
containing	NULL
anti-Tax	NULL
antibodies	NULL
,	NULL
rabbit	NULL
antiserum	NULL
specific	NULL
for	NULL
Bcel-x	NULL
;	NULL
,	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
Ky.	NULL
)	NULL
,	NULL
or	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
to	NULL
«	NULL
-tubulin	NULL
(	NULL
Oncogene	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
then	NULL
rinsed	NULL
,	NULL
and	NULL
finally	NULL
incubated	NULL
with	NULL
second	NULL
antibodies	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

Sites	NULL
of	NULL
antibody	NULL
binding	NULL
were	NULL
visualized	NULL
by	NULL
using	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
International	NULL
Plc	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
United	NULL
Kingdom	NULL
}	NULL
.	NULL

RPA	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
levels	NULL
of	NULL
belzl	NULL
,	NULL
bel-xs	NULL
,	NULL
bak	NULL
,	NULL
bax	NULL
,	NULL
bel-2	NULL
,	NULL
and	NULL
bad	NULL
gene	NULL
mRNAs	NULL
in	NULL
CTLL-2	NULL
cells	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
IL-2	NULL
for	NULL
48	NULL
h	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
RPA	NULL
)	NULL
with	NULL
the	NULL
RPA	NULL
II	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
Isogen	NULL
(	NULL
Nippon	NULL
Gene	NULL
,	NULL
Toyama	NULL
,	NULL
Japan	NULL
)	NULL
solution	NULL
,	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
separation	NULL
over	NULL
CHCl	NULL
,	NULL
and	NULL
precipitation	NULL
with	NULL
isopropanol	NULL
.	NULL

The	NULL
total	NULL
RNA	NULL
(	NULL
20	NULL
mg	NULL
)	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
``	NULL
P-labeled	NULL
antisense	NULL
RNA	NULL
probes	NULL
(	NULL
3	NULL
X	NULL
10*	NULL
cpm	NULL
)	NULL
overnight	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
hybridization	NULL
buffer	NULL
containing	NULL
80	NULL
%	NULL
formamide	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
RNase	NULL
A/T1	NULL
.	NULL

The	NULL
resultant	NULL
protected	NULL
RNAs	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
acrylamide	NULL
gel	NULL
with	NULL
8	NULL
M	NULL
urea	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

As	NULL
internal	NULL
controls	NULL
,	NULL
the	NULL
mRNA	NULL
levels	NULL
of	NULL
a	NULL
ribosomal	NULL
protein	NULL
(	NULL
L32	NULL
)	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

RNA	NULL
probes	NULL
used	NULL
for	NULL
this	NULL
assay	NULL
were	NULL
synthesized	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
with	NULL
templates	NULL
included	NULL
in	NULL
an	NULL
mAPO-2	NULL
multiprobe	NULL
template	NULL
set	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Transient-transfection	NULL
assay	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
bel-x	NULL
,	NULL
10°	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
pGL2-3.2	NULL
or	NULL
control	NULL
WT-Luc	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pSV-B-galactosidase	NULL
containing	NULL
the	NULL
bacterial	NULL
B-galactosidase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
,	NULL
and	NULL
an	NULL
effector	NULL
plasmid	NULL
containing	NULL
wild-type	NULL
or	NULL
mutant	NULL
Tax	NULL
at	NULL
a	NULL
1:2	NULL
molar	NULL
ratio	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
Luc	NULL
activity	NULL
in	NULL
the	NULL
cellular	NULL
lysates	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
luminometer	NULL
(	NULL
Lumat	NULL
;	NULL
Berthold	NULL
&	NULL
Co.	NULL
)	NULL
.	NULL

All	NULL
Luc	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicates	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
B-galactosidase	NULL
in	NULL
the	NULL
lysates	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Luc	NULL
activity	NULL
was	NULL
normalized	NULL
with	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

EMSA	NULL
.	NULL

Binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
to	NULL
NF-kB	NULL
elements	NULL
was	NULL
examined	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
J.	NULL
Virou	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
-a	NULL
bel-xl	NULL
-a	NULL
bel-xs	NULL
UW	NULL
a	NULL
»	NULL
#	NULL
#	NULL
B	NULL
a	NULL
»	NULL
#	NULL
B	NULL
#	NULL
B	NULL
a	NULL
»	NULL
-a	NULL
bak	NULL
w	NULL
we	NULL
a	NULL
»	NULL
a	NULL
»	NULL
a	NULL
»	NULL
as	NULL
an	NULL
an	NULL
-a	NULL
bax	NULL
a	NULL
#	NULL
an	NULL
#	NULL
»	NULL
#	NULL
#	NULL
»	NULL
#	NULL
B	NULL
#	NULL
p	NULL
-a	NULL
bci-2	NULL
-a	NULL
bad	NULL
L32	NULL
«	NULL
@	NULL
a	NULL
GAPDH	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
17	NULL
8	NULL
Nee	NULL
-	NULL
ques	NULL
«	NULL
.~	NULL
»	NULL
«	NULL
*	NULL
-	NULL
@	NULL
Bcl-x1	NULL
comm	NULL
mmm	NULL
came	NULL
A	NULL
)	NULL
)	NULL
)	NULL
:	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
bel-x/	NULL
mRNA	NULL
and	NULL
Bcl-x	NULL
,	NULL
protein	NULL
in	NULL
CTLL-2/Tax	NULL
transfectants	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RNase	NULL
protection	NULL
assays	NULL
with	NULL
specific	NULL
probes	NULL
for	NULL
bel-xl	NULL
,	NULL
bel-xs	NULL
,	NULL
bak	NULL
,	NULL
bax	NULL
,	NULL
bel-2	NULL
,	NULL
and	NULL
bad	NULL
genes	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
20	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
samples	NULL
extracted	NULL
from	NULL
CTLL-2/Vec-	NULL
#	NULL
22	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
CTLL-2/703-	NULL
#	NULL
23	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
CTLL-2/M22-	NULL
#	NULL
23	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
after	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
of	NULL
1	NULL
nM	NULL
IL-2	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
another	NULL
set	NULL
of	NULL
independent	NULL
clones	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
Bcl-x	NULL
;	NULL
,	NULL
(	NULL
top	NULL
)	NULL
and	NULL
«	NULL
-tubulin	NULL
(	NULL
bottom	NULL
)	NULL
expression	NULL
in	NULL
CTLL-2/Tax	NULL
transfectants	NULL
.	NULL

In	NULL
each	NULL
lane	NULL
,	NULL
we	NULL
used	NULL
50	NULL
ug	NULL
of	NULL
total	NULL
cell	NULL
lysates	NULL
prepared	NULL
from	NULL
a	NULL
similar	NULL
set	NULL
of	NULL
CTLL-2	NULL
clones	NULL
as	NULL
described	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
arrangement	NULL
of	NULL
lanes	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
panel	NULL
A	NULL
.	NULL

Specific	NULL
protein	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
another	NULL
set	NULL
of	NULL
independent	NULL
clones	NULL
.	NULL

brief	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
10	NULL
``	NULL
of	NULL
CTLL-2/Tax	NULL
transfectants	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
IL-2	NULL
for	NULL
48	NULL
h	NULL
were	NULL
preincubated	NULL
with	NULL
a	NULL
binding	NULL
buffer	NULL
containing	NULL
1	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

They	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
approximately	NULL
20,000	NULL
cpm	NULL
of	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
NF-kB	NULL
like	NULL
elements	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
DNA-protein	NULL
complex	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
NF-B-like	NULL
element	NULL
of	NULL
the	NULL
probes	NULL
,	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
probes	NULL
.	NULL

The	NULL
probes	NULL
or	NULL
competitors	NULL
utilized	NULL
were	NULL
prepared	NULL
by	NULL
annealing	NULL
the	NULL
sense	NULL
and	NULL
antisense	NULL
synthetic	NULL
oligonucleotides	NULL
as	NULL
follows	NULL
:	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
in	NULL
the	NULL
belx	NULL
promoter	NULL
,	NULL
5'-cgatAAAGGGACTTCCAAGat-3	NULL
'	NULL
and	NULL
3'-taTTTCCCTGAAGGTTCtage-5	NULL
'	NULL
;	NULL
NF-	NULL
«	NULL
B-like	NULL
mutant	NULL
clement	NULL
,	NULL
5'-cgatAA	NULL
ACCGACTTCCAAGat-3	NULL
'	NULL
and	NULL
3'-taTTTGGCTGAAGGTTCtage-5	NULL
'	NULL
;	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
of	NULL
SV40	NULL
early	NULL
promoter	NULL
,	NULL
5'-cgatAGAGGGGACTTITCCGat-3	NULL
'	NULL
and	NULL
3'-taTCTCCCCTGAAAGGCtage-5	NULL
'	NULL
;	NULL
and	NULL
typical	NULL
CRE	NULL
sequence	NULL
of	NULL
T-cell	NULL
receptor	NULL
«	NULL
promoter	NULL
,	NULL
5'-cgatCCATGACGTCATGGat-3	NULL
'	NULL
and	NULL
3'-taGGTACTG	NULL
CAGTACCtage-5	NULL
'	NULL
.	NULL

(	NULL
Lowercase	NULL
letters	NULL
signify	NULL
nonsense	NULL
nucleotides	NULL
inserted	NULL
to	NULL
make	NULL
cohesive	NULL
ends	NULL
,	NULL
which	NULL
increases	NULL
the	NULL
radiolabeling	NULL
efficiency	NULL
.	NULL
)	NULL

To	NULL
identify	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
in	NULL
the	NULL
DNA-protein	NULL
complex	NULL
by	NULL
EMSA	NULL
,	NULL
antibodies	NULL
specific	NULL
for	NULL
various	NULL
NF-kB	NULL
family	NULL
proteins	NULL
,	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p52	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
were	NULL
used	NULL
to	NULL
elicit	NULL
supershift	NULL
and/or	NULL
inhibition	NULL
of	NULL
the	NULL
bands	NULL
.	NULL

These	NULL
antibodies	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
radiolabeled	NULL
probes	NULL
in	NULL
EMSA	NULL
.	NULL

RESULTS	NULL
Constitutive	NULL
expression	NULL
of	NULL
be/-x	NULL
mRNA	NULL
and	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
in	NULL
CTLL-2	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

We	NULL
previously	NULL
established	NULL
CTLL-2	NULL
clones	NULL
stably	NULL
transfected	NULL
with	NULL
various	NULL
Tax	NULL
plasmids	NULL
such	NULL
as	NULL
wild-type	NULL
Tax	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
mutant	NULL
Tax	NULL
retaining	NULL
ability	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
703	NULL
)	NULL
,	NULL
or	NULL
mutant	NULL
Tax	NULL
defi-	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
25000	NULL
20000	NULL
-	NULL
T	NULL
15000	NULL
10000	NULL
-I	NULL
Luciferase	NULL
activity	NULL
5000	NULL
o	NULL
BA	NULL
wT	NULL
703	NULL
M22	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Transactivation	NULL
of	NULL
belx	NULL
promoter	NULL
by	NULL
Tax	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
2	NULL
g	NULL
of	NULL
the	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
pGL2-3.2	NULL
driven	NULL
by	NULL
the	NULL
beix	NULL
promoter	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
pSV-B-galactosidase	NULL
,	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
Tax-expressing	NULL
plasmids	NULL
or	NULL
its	NULL
control	NULL
vector	NULL
pHBAPr-1-neo	NULL
(	NULL
BA	NULL
)	NULL
.	NULL

The	NULL
Tax-expressing	NULL
plasmids	NULL
utilized	NULL
were	NULL
pBMT-2Tax	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
pBTax703	NULL
(	NULL
703	NULL
)	NULL
,	NULL
and	NULL
pBTaxM22	NULL
(	NULL
M22	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
with	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
the	NULL
standard	NULL
deviation	NULL
(	NULL
SD	NULL
)	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

cient	NULL
in	NULL
activating	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
M22	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

By	NULL
using	NULL
these	NULL
clones	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
CTLL-2	NULL
clones	NULL
transfected	NULL
with	NULL
WT	NULL
Tax	NULL
(	NULL
CTLL-2/WT	NULL
)	NULL
and	NULL
mutant	NULL
Tax	NULL
703	NULL
(	NULL
CTLL-2/703	NULL
)	NULL
but	NULL
not	NULL
the	NULL
parental	NULL
CTLL-2	NULL
or	NULL
CTLL-2	NULL
clones	NULL
transfected	NULL
with	NULL
Tax	NULL
M22	NULL
(	NULL
CTLL-2/M22	NULL
)	NULL
or	NULL
control	NULL
vector	NULL
(	NULL
CTLL-2/Vee	NULL
)	NULL
were	NULL
resistant	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

To	NULL
dissect	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
Tax-induced	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
CTLL-2	NULL
cells	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
NF-xB	NULL
SP-1	NULL
--	NULL
-	NULL
{	NULL
el	NULL
}	NULL
:	NULL
=	NULL
pGL2-3.2	NULL
_F	NULL
-1160	NULL
—D—o—	NULL
(	NULL
D—0—Mﬁé——|	NULL
:	NULL
pGL2	NULL
(	NULL
1160	NULL
)	NULL
_F	NULL
-848	NULL
WM	NULL
pGL2	NULL
(	NULL
848	NULL
)	NULL
_F	NULL
-822	NULL
WEDGLKSZZ	NULL
)	NULL
_F	NULL
631	NULL
--	NULL
é	NULL
&	NULL
@	NULL
-//4-C	NULL
--	NULL
pGL2	NULL
(	NULL
631	NULL
)	NULL
—F	NULL
s18	NULL
--	NULL
-	NULL
pGL2xBM	NULL
r	NULL
INDUCTION	NULL
OF	NULL
Bcl-x	NULL
,	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
THROUGH	NULL
NF-kB	NULL
-	NULL
7983	NULL
mRNA-levels	NULL
of	NULL
several	NULL
apoptosis-related	NULL
genes	NULL
,	NULL
including	NULL
be/-xl	NULL
,	NULL
bel-xs	NULL
,	NULL
bak	NULL
,	NULL
bax	NULL
,	NULL
bel-2	NULL
,	NULL
and	NULL
bad	NULL
in	NULL
CTLL-2/Tax	NULL
transfectants	NULL
,	NULL
by	NULL
using	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

A	NULL
representative	NULL
result	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

In	NULL
a	NULL
clone	NULL
of	NULL
CTLL-2/Vee	NULL
(	NULL
CTLL-2/Vec-	NULL
#	NULL
22	NULL
)	NULL
,	NULL
the	NULL
mRNA	NULL
level	NULL
of	NULL
bei-xl	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
,	NULL
was	NULL
markedly	NULL
decreased	NULL
after	NULL
48	NULL
h	NULL
of	NULL
IL-2	NULL
deprivation	NULL
.	NULL

Expression	NULL
of	NULL
bak	NULL
slightly	NULL
decreased	NULL
by	NULL
IL-2	NULL
deprivation	NULL
,	NULL
but	NULL
none	NULL
of	NULL
the	NULL
other	NULL
members	NULL
of	NULL
the	NULL
bel	NULL
family	NULL
tested	NULL
was	NULL
significantly	NULL
affected	NULL
by	NULL
IL-2	NULL
deprivation	NULL
.	NULL

Bei-xs	NULL
mRNA	NULL
,	NULL
a	NULL
spliced	NULL
variant	NULL
of	NULL
be/-xl	NULL
(	NULL
19	NULL
)	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
these	NULL
CTLL-2	NULL
cells	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
clones	NULL
of	NULL
CTLL-2/WT	NULL
and	NULL
CTLL-2/703	NULL
(	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
and	NULL
CTLL-2/703-	NULL
#	NULL
23	NULL
,	NULL
respectively	NULL
)	NULL
showed	NULL
a	NULL
constitutive	NULL
expression	NULL
of	NULL
bei-xl	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
bei-xl	NULL
mRNA	NULL
in	NULL
a	NULL
CTLL-2/M22	NULL
clone	NULL
(	NULL
CTLL-2/M22-	NULL
#	NULL
23	NULL
)	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
another	NULL
set	NULL
of	NULL
independent	NULL
clones	NULL
of	NULL
CTLL-2/Tax	NULL
transfectants	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
in	NULL
stable	NULL
CTLL-2	NULL
transfectants	NULL
with	NULL
Tax	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
and	NULL
CTLL-2/703-	NULL
#	NULL
23	NULL
but	NULL
not	NULL
CTLL-2/Vee	NULL
or	NULL
CTLL-2/M22-	NULL
#	NULL
23	NULL
expressed	NULL
detectable	NULL
levels	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
after	NULL
48	NULL
h	NULL
of	NULL
IL-2	NULL
deprivation	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
«	NULL
-tubulin	NULL
,	NULL
a	NULL
cytoskeletal	NULL
protein	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
was	NULL
comparable	NULL
among	NULL
these	NULL
clones	NULL
.	NULL

The	NULL
protein	NULL
levels	NULL
of	NULL
Bak	NULL
in	NULL
CTLL-2/WT	NULL
clones	NULL
did	NULL
not	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
CTLL-2/Vee	NULL
clones	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
in	NULL
CTLL-2/WT	NULL
and	NULL
CTLL-2/703	NULL
clones	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
may	NULL
contribute	NULL
to	NULL
Tax-induced	NULL
resistance	NULL
to	NULL
apoptosis	NULL
.	NULL

We	NULL
then	NULL
explored	NULL
the	NULL
mechanisms	NULL
of	NULL
Bcl-x	NULL
,	NULL
induction	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Transactivation	NULL
of	NULL
be/-x	NULL
promoter	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Using	NULL
transient-transfection	NULL
assays	NULL
,	NULL
we	NULL
then	NULL
assessed	NULL
whether	NULL
Tax	NULL
can	NULL
enhance	NULL
be/-x	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
these	NULL
assays	NULL
,	NULL
HTLV-1	NULL
Luciferase	NULL
activity	NULL
0	NULL
5000	NULL
10000	NULL
15000	NULL
20000	NULL
I	NULL
I	NULL
I	NULL
|	NULL
I	NULL
25000	NULL
I	NULL
+Tax	NULL
D	NULL
~Tax	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Mapping	NULL
of	NULL
HTLV-1	NULL
Tax-responsive	NULL
region	NULL
in	NULL
the	NULL
bex	NULL
promoter	NULL
.	NULL

A	NULL
series	NULL
of	NULL
Luc	NULL
reporter	NULL
plasmids	NULL
based	NULL
on	NULL
pGL2	NULL
vectors	NULL
containing	NULL
fragments	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
bel-x	NULL
gene	NULL
were	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
WT	NULL
Tax	NULL
plasmid	NULL
pBMT-2Tax	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
or	NULL
its	NULL
control	NULL
plasmid	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
together	NULL
with	NULL
reference	NULL
plasmid	NULL
pSV-B-galactosidase	NULL
.	NULL

Luciferase	NULL
activities	NULL
normalized	NULL
with	NULL
B-galactosidase	NULL
activities	NULL
after	NULL
48	NULL
h	NULL
of	NULL
incubation	NULL
are	NULL
indicated	NULL
.	NULL

Constructs	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
utilized	NULL
are	NULL
schematically	NULL
illustrated	NULL
in	NULL
the	NULL
left	NULL
panel	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
bel-x	NULL
gene	NULL
are	NULL
represented	NULL
by	NULL
heavy	NULL
lines	NULL
,	NULL
and	NULL
the	NULL
number	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
each	NULL
construct	NULL
indicate	NULL
the	NULL
5'-most	NULL
end	NULL
base	NULL
positions	NULL
from	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
of	NULL
the	NULL
bel-x	NULL
gene	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
NF-B	NULL
(	NULL
]	NULL
)	NULL
,	NULL
SP-1	NULL
(	NULL
{	NULL
}	NULL
)	NULL
,	NULL
Ets-1	NULL
(	NULL
@	NULL
)	NULL
and	NULL
GATA-1	NULL
(	NULL
¥	NULL
)	NULL
,	NULL
identified	NULL
by	NULL
using	NULL
a	NULL
transcription	NULL
factor	NULL
database	NULL
(	NULL
1a	NULL
)	NULL
,	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

pGL2	NULL
«	NULL
BM	NULL
contained	NULL
mutations	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
X	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

7984	NULL
TSUKAHARA	NULL
ET	NULL
AL	NULL
.	NULL

negative	NULL
IL-2-independent	NULL
human	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
but	NULL
not	NULL
CTLL-2	NULL
cells	NULL
were	NULL
used	NULL
since	NULL
CTLL-2	NULL
cells	NULL
can	NULL
not	NULL
survive	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
after	NULL
transfection	NULL
with	NULL
plasmids	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
Tax	NULL
effector	NULL
plasmids	NULL
and	NULL
a	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
(	NULL
pGL2-3.2	NULL
)	NULL
containing	NULL
a	NULL
3.2-kbp	NULL
segment	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
be/-x	NULL
gene	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
19	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
Luc	NULL
activities	NULL
of	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
WT	NULL
Tax	NULL
or	NULL
Tax	NULL
703	NULL
were	NULL
seven	NULL
to	NULL
nine	NULL
times	NULL
higher	NULL
than	NULL
those	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
.	NULL

However	NULL
,	NULL
Luc	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
Tax	NULL
M22	NULL
plasmid	NULL
was	NULL
almost	NULL
equivalent	NULL
to	NULL
that	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
both	NULL
WT	NULL
Tax	NULL
and	NULL
Tax	NULL
703	NULL
transactivates	NULL
bex	NULL
promoter	NULL
activity	NULL
,	NULL
presumably	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

Mapping	NULL
of	NULL
HTLV-1	NULL
Tax-responsive	NULL
regions	NULL
in	NULL
the	NULL
bex	NULL
promoter	NULL
.	NULL

We	NULL
next	NULL
mapped	NULL
Tax-responsive	NULL
elements	NULL
in	NULL
the	NULL
mouse	NULL
be/-x	NULL
promoter	NULL
.	NULL

Several	NULL
consensus	NULL
motifs	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
SP-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
GATA-1	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
also	NULL
identified	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
motif	NULL
(	NULL
GGGACTTCC	NULL
)	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
in	NULL
the	NULL
immunoglobulin	NULL
promoter	NULL
,	NULL
which	NULL
was	NULL
located	NULL
at	NULL
positions	NULL
-848	NULL
to	NULL
-840	NULL
of	NULL
the	NULL
bel-x	NULL
promoter	NULL
in	NULL
an	NULL
inverted	NULL
direction	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
contributions	NULL
of	NULL
these	NULL
sites	NULL
for	NULL
Tax-induced	NULL
transactivation	NULL
,	NULL
a	NULL
series	NULL
of	NULL
Luc	NULL
reporter	NULL
constructs	NULL
with	NULL
several	NULL
fragments	NULL
of	NULL
different	NULL
lengths	NULL
of	NULL
5	NULL
'	NULL
deleted	NULL
bei-x	NULL
promoters	NULL
were	NULL
prepared	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
Tax	NULL
expression	NULL
plasmid	NULL
or	NULL
control	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
highest	NULL
level	NULL
of	NULL
Tax-induced	NULL
Luc	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
longest	NULL
construct	NULL
,	NULL
pGL2-3.2	NULL
.	NULL

The	NULL
two	NULL
deletion	NULL
constructs	NULL
,	NULL
pGL2	NULL
(	NULL
1160	NULL
)	NULL
and	NULL
pGL2	NULL
(	NULL
848	NULL
)	NULL
,	NULL
also	NULL
responded	NULL
to	NULL
Tax	NULL
significantly	NULL
.	NULL

All	NULL
three	NULL
constructs	NULL
contained	NULL
both	NULL
SP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site-like	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
the	NULL
Tax-induced	NULL
Luc	NULL
activity	NULL
was	NULL
markedly	NULL
reduced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
pGL2	NULL
(	NULL
822	NULL
)	NULL
,	NULL
which	NULL
had	NULL
the	NULL
SP-1	NULL
but	NULL
not	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
.	NULL

The	NULL
shortest	NULL
construct	NULL
pGL2	NULL
(	NULL
631	NULL
)	NULL
,	NULL
which	NULL
lacked	NULL
both	NULL
the	NULL
NF-kB	NULL
and	NULL
the	NULL
SP-1	NULL
sites	NULL
,	NULL
elicited	NULL
minimal	NULL
responses	NULL
to	NULL
Tax	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
mutated	NULL
NF-	NULL
«	NULL
B-Lue	NULL
plasmid	NULL
,	NULL
pGL	NULL
«	NULL
BM	NULL
,	NULL
which	NULL
had	NULL
the	NULL
same	NULL
length	NULL
as	NULL
pGL2	NULL
(	NULL
848	NULL
)	NULL
but	NULL
had	NULL
a	NULL
CC-to-GG	NULL
mutation	NULL
at	NULL
positions	NULL
-841	NULL
and	NULL
-840	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
,	NULL
exhibited	NULL
markedly	NULL
reduced	NULL
levels	NULL
of	NULL
Tax-induced	NULL
transactivation	NULL
as	NULL
observed	NULL
with	NULL
pGL2	NULL
(	NULL
822	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
NF-kB	NULL
site	NULL
located	NULL
at	NULL
positions	NULL
-848	NULL
to	NULL
-840	NULL
in	NULL
the	NULL
be/-x	NULL
gene	NULL
promoter	NULL
region	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
responsive	NULL
elements	NULL
of	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
be/kx	NULL
.	NULL

Binding	NULL
of	NULL
NF-KB	NULL
family	NULL
proteins	NULL
to	NULL
the	NULL
NF-	NULL
element	NULL
in	NULL
bel-x	NULL
promoter	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
can	NULL
actually	NULL
bind	NULL
to	NULL
the	NULL
putative	NULL
NF-kB	NULL
element	NULL
identified	NULL
in	NULL
the	NULL
be/-x	NULL
promoter	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-kB-site	NULL
at	NULL
positions	NULL
of	NULL
-848	NULL
to	NULL
-840	NULL
in	NULL
the	NULL
bel-x	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
a	NULL
clear	NULL
shifted	NULL
band	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
CTLL-2/Vec-	NULL
#	NULL
22	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
parental	NULL
CTLL-2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Complex	NULL
formation	NULL
was	NULL
competed	NULL
by	NULL
100-fold	NULL
excess	NULL
cold	NULL
probe	NULL
or	NULL
unlabeled	NULL
oligonucleotides	NULL
with	NULL
a	NULL
typical	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
of	NULL
SV40	NULL
early	NULL
promoter	NULL
but	NULL
not	NULL
by	NULL
oligonucleotides	NULL
with	NULL
a	NULL
mutant	NULL
NF-	NULL
«	NULL
B-like	NULL
sequence	NULL
of	NULL
the	NULL
be/-x	NULL
promoter	NULL
or	NULL
other	NULL
unrelated	NULL
competitors	NULL
such	NULL
as	NULL
CRE	NULL
sequence	NULL
.	NULL

When	NULL
the	NULL
mutant	NULL
NF-	NULL
«	NULL
B-like	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
complex	NULL
formation	NULL
was	NULL
not	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

When	NULL
anti-NF-kB	NULL
p50	NULL
antibody	NULL
was	NULL
preincubated	NULL
with	NULL
nuclear	NULL
factors	NULL
of	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
,	NULL
the	NULL
bands	NULL
formed	NULL
with	NULL
the	NULL
probes	NULL
supershifted	NULL
in	NULL
the	NULL
EMSA	NULL
,	NULL
whereas	NULL
anti-NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
anti-ReIB	NULL
partially	NULL
J.	NULL
Virou	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
-	NULL
U	NULL
WU	NULL
WW	NULL
=-i	NULL
%	NULL
I	NULL
'	NULL
!	NULL

B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
``	NULL
“	NULL
H	NULL
“	NULL
u	NULL
“	NULL
“	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
to	NULL
*°P-labeled	NULL
oligonucleotide	NULL
probes	NULL
in	NULL
EMSA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
from	NULL
CTLL-2/Vec-	NULL
#	NULL
22	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
CTLL-2/WT	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
9	NULL
)	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
9	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
8	NULL
)	NULL
of	NULL
IL-2	NULL
were	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
and	NULL
9	NULL
)	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
competitors	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
probes	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
in	NULL
the	NULL
be/x	NULL
promoter	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Competitors	NULL
used	NULL
included	NULL
unlabeled	NULL
probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
element	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
a	NULL
typical	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
a	NULL
typical	NULL
CRE	NULL
sequence	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
the	NULL
band	NULL
of	NULL
probes	NULL
alone	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
containing	NULL
a	NULL
mutant	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
were	NULL
also	NULL
incubated	NULL
without	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
nuclear	NULL
extracts	NULL
from	NULL
CTLL-2/WT	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

Specific	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
g	NULL
)	NULL
from	NULL
IL-2-untreated	NULL
CTLL-2/WT	NULL
were	NULL
preincubated	NULL
without	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
,	NULL
including	NULL
NF-xB	NULL
p65	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
RelB	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p52	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
control	NULL
rabbit	NULL
antiserum	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
probe	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
in	NULL
the	NULL
bex	NULL
promoter	NULL
.	NULL

The	NULL
lower	NULL
arrow	NULL
indicates	NULL
NF-xB-DNA	NULL
complex	NULL
alone	NULL
,	NULL
while	NULL
the	NULL
upper	NULL
arrow	NULL
indicates	NULL
a	NULL
supershifted	NULL
band	NULL
with	NULL
an	NULL
anti-NF-	NULL
«	NULL
B	NULL
p50	NULL
antibody	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
CTLL-2/WT	NULL
clones	NULL
.	NULL

inhibited	NULL
the	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
supershift	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
a	NULL
typical	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
p65	NULL
and	NULL
p50	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
RelB	NULL
can	NULL
bind	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
element	NULL
identified	NULL
in	NULL
the	NULL
be/-x	NULL
promoter	NULL
.	NULL

Suppression	NULL
of	NULL
Tax-induced	NULL
enhancement	NULL
of	NULL
be/-x	NULL
promoter	NULL
activity	NULL
by	NULL
blocking	NULL
NF-B	NULL
pathway	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
whether	NULL
blocking	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
can	NULL
affect	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
bei-x/	NULL
by	NULL
transient	NULL
assays	NULL
by	NULL
using	NULL
a	NULL
super-repressor	NULL
form	NULL
of	NULL
IxBa	NULL
mutant	NULL
(	NULL
IxBaM	NULL
)	NULL
that	NULL
specifically	NULL
suppresses	NULL
NF-xB	NULL
activity	NULL
.	NULL

IxBaM	NULL
contains	NULL
serine	NULL
to	NULL
alanine	NULL
mutations	NULL
at	NULL
residues	NULL
32	NULL
and	NULL
36	NULL
,	NULL
which	NULL
abolish	NULL
phosphorylation	NULL
sites	NULL
by	NULL
IxB	NULL
kinase	NULL
.	NULL

The	NULL
IxBaM	NULL
expression	NULL
vector	NULL
was	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
WT	NULL
Tax	NULL
plasmid	NULL
and	NULL
the	NULL
pGL2-3.2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
the	NULL
elevated	NULL
Luc	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
WT	NULL
Tax	NULL
was	NULL
markedly	NULL
suppressed	NULL
by	NULL
cotransfec-tion	NULL
with	NULL
IxBaM	NULL
but	NULL
not	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
A	NULL
25000	NULL
pGL2-3.2	NULL
up	NULL
20000	NULL
P.	NULL
b-Z	NULL
I	NULL
15000	NULL
®	NULL
4	NULL
Cal	NULL
a	NULL
im	NULL
10000	NULL
£	NULL
&	NULL
k=l	NULL
jul	NULL
5000	NULL
0	NULL
J	NULL
pBMT-2Tax	NULL
-	NULL
-	NULL
+	NULL
4	NULL
peDNA3-IxBaM	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
INDUCTION	NULL
OF	NULL
Bcl-x	NULL
,	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
THROUGH	NULL
NF-kB	NULL
-	NULL
7985	NULL
B	NULL
80000	NULL
WT-Lue	NULL
60000	NULL
-	NULL
as	NULL
4	NULL
40000	NULL
20000	NULL
o	NULL
--	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
be/-x	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
4	NULL
mg	NULL
of	NULL
bel-x/	NULL
promoter-Luc	NULL
reporter	NULL
plasmid	NULL
pGL2-3.2	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
pSV-B-galactosidase	NULL
,	NULL
and	NULL
various	NULL
combinations	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
pBMT-2Tax	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
pcDNA3-IxBoM	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
total	NULL
plasmid	NULL
amount	NULL
for	NULL
transfection	NULL
was	NULL
always	NULL
adjusted	NULL
up	NULL
to	NULL
9	NULL
pg	NULL
by	NULL
adding	NULL
control	NULL
plasmids	NULL
pHBAPr-1-neo	NULL
or	NULL
pcDNA3	NULL
.	NULL

The	NULL
Luc	NULL
activity	NULL
of	NULL
the	NULL
samples	NULL
after	NULL
48	NULL
h	NULL
of	NULL
incubation	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
the	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Control	NULL
experiments	NULL
with	NULL
reporter	NULL
plasmids	NULL
without	NULL
potential	NULL
NF-xB	NULL
binding	NULL
sites	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
HTLV-LTR	NULL
(	NULL
21	NULL
bp	NULL
)	NULL
-Luc	NULL
reporter	NULL
plasmid	NULL
WT-Luc	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
pBMT-2Tax	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pSV-B-galactosidase	NULL
,	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
pcDNA3-IxBaM	NULL
or	NULL
pecDNA3	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
indicated	NULL
as	NULL
described	NULL
in	NULL
panel	NULL
A.	NULL
the	NULL
Luc	NULL
activity	NULL
of	NULL
another	NULL
Luc	NULL
reporter	NULL
plasmid	NULL
,	NULL
WT-Luc	NULL
,	NULL
which	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
Tax	NULL
through	NULL
the	NULL
CRE	NULL
pathway	NULL
but	NULL
not	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
(	NULL
16	NULL
)	NULL
,	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
IxBaM	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
the	NULL
NF-kB	NULL
pathway	NULL
was	NULL
involved	NULL
in	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
the	NULL
bel-x	NULL
promoter	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Involvement	NULL
of	NULL
NF-B	NULL
pathway	NULL
in	NULL
constitutive	NULL
bei-xl	NULL
promoter	NULL
activity	NULL
in	NULL
CTLL-2/Tax	NULL
transfectants	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
examined	NULL
involvement	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
Tax-induced	NULL
constitutive	NULL
expression	NULL
of	NULL
be/-xl	NULL
in	NULL
CTLL-2	NULL
cells	NULL
.	NULL

CTLL-2/WT-	NULL
#	NULL
34	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
pGL2-3.2	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IxBaM	NULL
in	NULL
IL-2-free	NULL
conditions	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
the	NULL
bel-x	NULL
promoter	NULL
activity	NULL
in	NULL
CTLL-2/WT-	NULL
#	NULL
34	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
transfection	NULL
with	NULL
IxBaM	NULL
but	NULL
not	NULL
with	NULL
control	NULL
plasmid	NULL
.	NULL

The	NULL
Luc	NULL
activity	NULL
of	NULL
WT-Luc	NULL
lacking	NULL
potential	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
IxBaM	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
CTLL-2/WT	NULL
clones	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
be/-xl	NULL
in	NULL
CTLL-2	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
transactivates	NULL
the	NULL
bel-x	NULL
promoter	NULL
through	NULL
NF-kB	NULL
.	NULL

Tax-mediated	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
in	NULL
CTLL-2	NULL
cells	NULL
expressing	NULL
Tax	NULL
is	NULL
presumed	NULL
to	NULL
prevent	NULL
these	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
.	NULL

This	NULL
can	NULL
be	NULL
one	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
apoptosis	NULL
resistance	NULL
shown	NULL
in	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
Tax	NULL
converted	NULL
IL-2-dependent	NULL
growth	NULL
of	NULL
CTLL-2	NULL
to	NULL
IL-2-independent	NULL
growth	NULL
(	NULL
23	NULL
)	NULL
.	NULL

RNA	NULL
protection	NULL
assays	NULL
showed	NULL
that	NULL
be/-x/	NULL
,	NULL
but	NULL
not	NULL
other	NULL
members	NULL
of	NULL
be	NULL
!	NULL

family	NULL
tested	NULL
,	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
CTLL-2/WT	NULL
and	NULL
CTLL-2/703	NULL
clones	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
protein	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Bel-x	NULL
,	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
of	NULL
several	NULL
types	NULL
of	NULL
cells	NULL
including	NULL
T	NULL
lympho-	NULL
cytes	NULL
(	NULL
4	NULL
,	NULL
32	NULL
)	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
protects	NULL
CTLL-2	NULL
cells	NULL
against	NULL
apoptosis	NULL
after	NULL
IL-2	NULL
deprivation	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Tax-induced	NULL
constitutive	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
can	NULL
be	NULL
the	NULL
underlying	NULL
molecular	NULL
mechanism	NULL
of	NULL
resistance	NULL
of	NULL
CTLL-2	NULL
cells	NULL
expressing	NULL
Tax	NULL
to	NULL
apoptosis	NULL
after	NULL
IL-2	NULL
deprivation	NULL
.	NULL

Other	NULL
investigators	NULL
,	NULL
however	NULL
,	NULL
reported	NULL
that	NULL
the	NULL
otherwise	NULL
IL-3-depen-dent	NULL
B	NULL
cells	NULL
could	NULL
grow	NULL
independently	NULL
of	NULL
IL-3	NULL
when	NULL
they	NULL
expressed	NULL
both	NULL
Tax	NULL
and	NULL
c-Myc	NULL
but	NULL
not	NULL
Tax	NULL
or	NULL
c-Myc	NULL
alone	NULL
(	NULL
28	NULL
)	NULL
.	NULL

bel-xl	NULL
induction	NULL
by	NULL
Tax	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Such	NULL
variation	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
induce	NULL
be/-x/	NULL
among	NULL
different	NULL
A	NULL
B	NULL
pGL2-3.2	NULL
WTLue	NULL
100	NULL
4	NULL
100	NULL
4	NULL
1	NULL
a	NULL
S	NULL
rs	NULL
.	NULL

75	NULL
7	NULL
2	NULL
'	NULL
3	NULL
4	NULL
a	NULL
§	NULL
50	NULL
7	NULL
[	NULL
50	NULL
7	NULL
M	NULL
€	NULL
3	NULL
l	NULL
254	NULL
25	NULL
4	NULL
0	NULL
T	NULL
0	NULL
T	NULL
peDNA3-IxBoM	NULL
-	NULL
+	NULL
-	NULL
+	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Inhibition	NULL
of	NULL
constitutive	NULL
activation	NULL
of	NULL
promoter	NULL
in	NULL
CTLL-2/Tax	NULL
transfectants	NULL
by	NULL
IxBaM	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CTLL-2/WT	NULL
clone	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pGL2-3.2	NULL
,	NULL
pSV-B-galactosidase	NULL
,	NULL
and	NULL
either	NULL
peDNA3-IxBaM	NULL
(	NULL
solid	NULL
bar	NULL
)	NULL
or	NULL
peDNA3	NULL
(	NULL
open	NULL
bar	NULL
)	NULL
.	NULL

Luc	NULL
activity	NULL
after	NULL
48	NULL
h	NULL
of	NULL
incubation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
and	NULL
indicated	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
activity	NULL
in	NULL
the	NULL
IxBaM	NULL
(	NULL
-	NULL
)	NULL
sample	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
the	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Control	NULL
experiments	NULL
with	NULL
the	NULL
WT-Luc	NULL
reporter	NULL
plasmid	NULL
instead	NULL
of	NULL
pGL2-3.2	NULL
.	NULL

7986	NULL
TSUKAHARA	NULL
ET	NULL
AL	NULL
.	NULL

cell	NULL
types	NULL
implies	NULL
a	NULL
requirement	NULL
of	NULL
cellular	NULL
mediators	NULL
in	NULL
this	NULL
phenomenon	NULL
.	NULL

Although	NULL
Bcel-2	NULL
is	NULL
also	NULL
known	NULL
to	NULL
protect	NULL
cells	NULL
against	NULL
apoptosis	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
be/-2	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
Tax-induced	NULL
resistance	NULL
to	NULL
apoptosis	NULL
of	NULL
CTLL-2	NULL
in	NULL
the	NULL
present	NULL
system	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
previous	NULL
reports	NULL
demonstrating	NULL
that	NULL
Tax	NULL
did	NULL
not	NULL
induce	NULL
be/-2	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
and	NULL
a	NULL
pro-B	NULL
cell	NULL
line	NULL
(	NULL
28	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
bax	NULL
,	NULL
an	NULL
accelerator	NULL
of	NULL
apoptosis	NULL
,	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
Tax	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

However	NULL
,	NULL
other	NULL
investigators	NULL
reported	NULL
that	NULL
Tax	NULL
repressed	NULL
bex	NULL
transcription	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
Bcl-2/Bax	NULL
and	NULL
Bcl-x	NULL
,	NULL
/Bax	NULL
ratios	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
determinants	NULL
of	NULL
apoptosis	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
of	NULL
Tax-induced	NULL
activation	NULL
of	NULL
be/-xl	NULL
,	NULL
together	NULL
with	NULL
the	NULL
finding	NULL
of	NULL
Tax-induced	NULL
repression	NULL
of	NULL
bex	NULL
by	NULL
others	NULL
,	NULL
suggest	NULL
that	NULL
Tax	NULL
inhibits	NULL
apoptosis	NULL
by	NULL
increasing	NULL
the	NULL
Bcl-x	NULL
,	NULL
/Bax	NULL
ratio	NULL
in	NULL
HTLV-1-in-fected	NULL
cells	NULL
.	NULL

Tax	NULL
is	NULL
known	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
activating	NULL
IxB	NULL
kinases	NULL
and	NULL
other	NULL
related	NULL
molecules	NULL
(	NULL
8	NULL
,	NULL
17	NULL
,	NULL
47	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB	NULL
pathway	NULL
in	NULL
Tax-induced	NULL
transactivation	NULL
of	NULL
be/-xl	NULL
was	NULL
strongly	NULL
suggested	NULL
by	NULL
our	NULL
results	NULL
that	NULL
the	NULL
be/-x	NULL
promoter	NULL
was	NULL
activated	NULL
by	NULL
mutant	NULL
Tax	NULL
preferentially	NULL
activating	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
that	NULL
an	NULL
NF-kB-like	NULL
element	NULL
at	NULL
positions	NULL
-848	NULL
to	NULL
-840	NULL
from	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
of	NULL
bei-x	NULL
gene	NULL
was	NULL
responsive	NULL
for	NULL
Tax-induced	NULL
activation	NULL
of	NULL
the	NULL
be/-x	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NF-kB	NULL
family	NULL
proteins	NULL
,	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
NF-	NULL
«	NULL
kB	NULL
p50	NULL
,	NULL
and	NULL
RelB	NULL
,	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
that	NULL
we	NULL
identified	NULL
in	NULL
the	NULL
mouse	NULL
be/-x	NULL
promoter	NULL
was	NULL
also	NULL
confirmed	NULL
in	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Similar	NULL
NF-kB	NULL
binding	NULL
sequences	NULL
were	NULL
also	NULL
found	NULL
in	NULL
the	NULL
human	NULL
be/-x	NULL
promoter	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
Tax-mediated	NULL
be	NULL
!	NULL

-x	NULL
promoter	NULL
activation	NULL
was	NULL
profoundly	NULL
inhibited	NULL
by	NULL
a	NULL
super-repressor	NULL
mutant	NULL
of	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
by	NULL
introduction	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
in	NULL
the	NULL
mouse	NULL
bel-x	NULL
promoter	NULL
constructs	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
element	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
responsive	NULL
regions	NULL
of	NULL
Tax-induced	NULL
be/-x	NULL
promoter	NULL
activation	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
induced	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
or	NULL
immunoglobulin	NULL
G	NULL
cross-linking	NULL
in	NULL
several	NULL
types	NULL
of	NULL
cells	NULL
unrelated	NULL
to	NULL
HTLV-1	NULL
(	NULL
48	NULL
,	NULL
49	NULL
,	NULL
51	NULL
)	NULL
.	NULL

A	NULL
few	NULL
reports	NULL
suggested	NULL
the	NULL
involvement	NULL
of	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
protein	NULL
(	NULL
50	NULL
)	NULL
and	NULL
IEX-1L	NULL
(	NULL
52	NULL
)	NULL
,	NULL
although	NULL
these	NULL
could	NULL
be	NULL
a	NULL
part	NULL
of	NULL
multiple	NULL
mechanisms	NULL
and	NULL
may	NULL
also	NULL
vary	NULL
among	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
of	NULL
NF-	NULL
«	NULL
B-induced	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
apart	NULL
from	NULL
the	NULL
bei-x/	NULL
induction	NULL
demonstrated	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
demonstrated	NULL
in	NULL
the	NULL
present	NULL
study	NULL
that	NULL
Tax	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
,	NULL
at	NULL
least	NULL
through	NULL
the	NULL
NF-kB	NULL
pathway	NULL
,	NULL
and	NULL
that	NULL
this	NULL
was	NULL
associated	NULL
with	NULL
cellular	NULL
resistance	NULL
to	NULL
apoptosis	NULL
.	NULL

Tax-mediated	NULL
Bcl-x	NULL
,	NULL
induction	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
underlying	NULL
mechanisms	NULL
of	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
of	NULL
HTLV-1	NULL
infected	NULL
cells	NULL
,	NULL
which	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
HTLV-1	NULL
infection	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
K.	NULL
Matumoto	NULL
(	NULL
Osaka	NULL
Red	NULL
Cross	NULL
Center	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
;	NULL
J.	NULL
Fujisawa	NULL
(	NULL
Kansai	NULL
Medical	NULL
University	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
;	NULL
and	NULL
J.	NULL
Inoue	NULL
(	NULL
Tokyo	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
providing	NULL
pHBAPr-1-neo	NULL
;	NULL
pBMT-2Tax	NULL
,	NULL
pBTax703	NULL
,	NULL
pBTaxM22	NULL
,	NULL
and	NULL
WT-Luc	NULL
;	NULL
and	NULL
IxBaM	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
F.	NULL
G.	NULL
Issa	NULL
,	NULL
Word-Medex	NULL
,	NULL
Sydney	NULL
,	NULL
Australia	NULL
,	NULL
for	NULL
the	NULL
careful	NULL
reading	NULL
and	NULL
editing	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Agency	NULL
of	NULL
Science	NULL
and	NULL
Technology	NULL
of	NULL
Japan	NULL
,	NULL
and	NULL
Core	NULL
Research	NULL
for	NULL
Evolutional	NULL
Science	NULL
and	NULL
Technology	NULL
of	NULL
Japan	NULL
Science	NULL
and	NULL
Technology	NULL
Corpora-tion	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akagi	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Ono	NULL
,	NULL
and	NULL
K.	NULL
Shimotohno	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
T	NULL
cells	NULL
immortalized	NULL
by	NULL
Tax1	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Blood	NULL
86:4243-4249.	NULL
la.Akiyama	NULL
,	NULL
Y	NULL
.	NULL

12	NULL
May	NULL
1998	NULL
,	NULL
posting	NULL
date	NULL
.	NULL

TFSEARCH	NULL
.	NULL

[	NULL
Online	NULL
.	NULL
]	NULL

http	NULL
:	NULL
//pdap1.tre.rwep.or.jp/research/db/TFSEARCHLhtml	NULL
.	NULL

[	NULL
1	NULL
February	NULL
1999	NULL
,	NULL
last	NULL
date	NULL
accessed	NULL
.	NULL
]	NULL

2	NULL
.	NULL

Arai	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Kannagi	NULL
,	NULL
M.	NULL
Matsuoka	NULL
,	NULL
T.	NULL
Sato	NULL
,	NULL
N.	NULL
Yamamoto	NULL
,	NULL
and	NULL
M.	NULL
Fujii	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
of	NULL
FAP-1	NULL
(	NULL
Fas-associated	NULL
phosphatase	NULL
)	NULL
and	NULL
resistance	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
l-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
patients	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
14:261-267	NULL
.	NULL

3	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
C.	NULL
L.	NULL
McShan	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1996	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
cell	NULL
survival	NULL
gene	NULL
bel-x	NULL
,	NULL
improves	NULL
the	NULL
viability	NULL
of	NULL
CTLL-2	NULL
cells	NULL
without	NULL
affecting	NULL
their	NULL
IL-2	NULL
proliferative	NULL
response	NULL
.	NULL

Implications	NULL
for	NULL
the	NULL
development	NULL
of	NULL
bioassays	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
191:143-148	NULL
.	NULL

4	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
A.	NULL
Accavitti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bcl-X	NULL
;	NULL
.	NULL

Immunity	NULL
3:87-98	NULL
.	NULL

5	NULL
.	NULL

Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
E.	NULL
Garrus	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1997	NULL
.	NULL

Repression	NULL
of	NULL
bax	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
:	NULL
implications	NULL
for	NULL
suppression	NULL
of	NULL
apoptosis	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
.	NULL

Virology	NULL
231:135-140	NULL
.	NULL

6	NULL
.	NULL

Chen	NULL
,	NULL
I	NULL
S.	NULL
,	NULL
A.	NULL
J.	NULL
Cann	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1985	NULL
.	NULL

Functional	NULL
relation	NULL
between	NULL
HTLV-II	NULL
x	NULL
and	NULL
adenovirus	NULL
E1A	NULL
proteins	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Science	NULL
230:570-573	NULL
.	NULL

7	NULL
.	NULL

Chlichlia	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Moldenhauer	NULL
,	NULL
P.	NULL
T.	NULL
Daniel	NULL
,	NULL
M.	NULL
Busslinger	NULL
,	NULL
L.	NULL
Gazzolo	NULL
,	NULL
V.	NULL
Schirmacher	NULL
,	NULL
and	NULL
K.	NULL
Khazaie	NULL
.	NULL

1995	NULL
.	NULL

Immediate	NULL
effects	NULL
of	NULL
reversible	NULL
HTLV-1	NULL
tax	NULL
function	NULL
:	NULL
T-cell	NULL
activation	NULL
and	NULL
apoptosis	NULL
.	NULL

Oncogene	NULL
10:269-277	NULL
.	NULL

8	NULL
.	NULL

Chu	NULL
,	NULL
Z.	NULL
L.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
J.	NULL
Hawiger	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Tax	NULL
oncoprotein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
associates	NULL
with	NULL
and	NULL
persistently	NULL
activates	NULL
IxB	NULL
kinases	NULL
containing	NULL
IKKa	NULL
and	NULL
IKK	NULL
$	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:15891-15894	NULL
.	NULL

9	NULL
.	NULL

Copeland	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
A.	NULL
G.	NULL
Haaksma	NULL
,	NULL
J.	NULL
Goudsmit	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Heeney	NULL
.	NULL

1994	NULL
.	NULL

Inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
10:1259-1268	NULL
.	NULL

10	NULL
.	NULL

Cory	NULL
,	NULL
S.	NULL
1995	NULL
.	NULL

Regulation	NULL
of	NULL
lymphocyte	NULL
survival	NULL
by	NULL
the	NULL
bel-2	NULL
gene	NULL
family	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:513-543	NULL
.	NULL

11	NULL
.	NULL

Deng	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
Podack	NULL
.	NULL

1993	NULL
.	NULL

Suppression	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
cytotoxic	NULL
T-cell	NULL
line	NULL
by	NULL
interleukin	NULL
2-mediated	NULL
gene	NULL
transcription	NULL
and	NULL
deregulated	NULL
expression	NULL
of	NULL
the	NULL
protooncogene	NULL
bel-2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2189-2193	NULL
.	NULL

12	NULL
.	NULL

Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
D.	NULL
T.	NULL
Stephenson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Clemens	NULL
,	NULL
and	NULL
S.	NULL
P.	NULL
Little	NULL
.	NULL

1997	NULL
.	NULL

Bcl-X	NULL
.	NULL

,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
is	NULL
elevated	NULL
following	NULL
severe	NULL
global	NULL
ischemia	NULL
in	NULL
rat	NULL
brains	NULL
.	NULL

Brain	NULL
Res	NULL
.	NULL

776:222-229	NULL
.	NULL

13	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
H.	NULL
Paskalis	NULL
,	NULL
C.	NULL
Kleinman-Ewing	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
pX	NULL
protein	NULL
of	NULL
HTLV-I	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
its	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

Science	NULL
229:675-679	NULL
.	NULL

14	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Niki	NULL
,	NULL
T.	NULL
Mori	NULL
,	NULL
T.	NULL
Matsuda	NULL
,	NULL
M.	NULL
Matsui	NULL
,	NULL
N.	NULL
Nomura	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1991	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
induces	NULL
expression	NULL
of	NULL
various	NULL
immediate	NULL
carly	NULL
serum	NULL
responsive	NULL
genes	NULL
.	NULL

Oncogene	NULL
6:1023-1029	NULL
.	NULL

15	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Kiyokawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1985	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
by	NULL
a	NULL
trans-acting	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:2277-2281	NULL
.	NULL

16	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
T.	NULL
Yoshimura	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
indirect	NULL
association	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
tax	NULL
protein	NULL
with	NULL
DNA	NULL
results	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4525-4528	NULL
.	NULL

17	NULL
.	NULL

Geleziunas	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Ferrell	NULL
,	NULL
X.	NULL
Lin	NULL
,	NULL
Y.	NULL
Mu	NULL
,	NULL
E.	NULL
T.	NULL
Cunningham	NULL
,	NULL
Jr.	NULL
,	NULL
M.	NULL
Grant	NULL
,	NULL
M.	NULL
A.	NULL
Connelly	NULL
,	NULL
J.	NULL
E.	NULL
Hambor	NULL
,	NULL
K.	NULL
B.	NULL
Marcu	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
induction	NULL
of	NULL
NF-B	NULL
involves	NULL
activation	NULL
of	NULL
the	NULL
IxB	NULL
kinase	NULL
alpha	NULL
(	NULL
IKKa	NULL
)	NULL
and	NULL
IKKB	NULL
cellular	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:5157-65	NULL
.	NULL

18	NULL
.	NULL

Gillis	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1977	NULL
.	NULL

Long	NULL
term	NULL
culture	NULL
of	NULL
tumour-specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
268:154-156	NULL
.	NULL

(	NULL
Letter	NULL
.	NULL
)	NULL

19	NULL
.	NULL

Grillot	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
M.	NULL
Gonzalez-Garcia	NULL
,	NULL
D.	NULL
Ekhterae	NULL
,	NULL
L.	NULL
Duan	NULL
,	NULL
N.	NULL
Inohara	NULL
,	NULL
S.	NULL
Ohta	NULL
,	NULL
M.	NULL
F.	NULL
Seldin	NULL
,	NULL
and	NULL
G.	NULL
Nunez	NULL
.	NULL

1997	NULL
.	NULL

Genomic	NULL
organization	NULL
,	NULL
promoter	NULL
region	NULL
analysis	NULL
,	NULL
and	NULL
chromosome	NULL
localization	NULL
of	NULL
the	NULL
mouse	NULL
bel-x	NULL
gene	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:4750-4757	NULL
.	NULL

20	NULL
.	NULL

Grossman	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
T.	NULL
Kimata	NULL
,	NULL
F.	NULL
H.	NULL
Wong	NULL
,	NULL
M.	NULL
Zutter	NULL
,	NULL
T.	NULL
J.	NULL
Ley	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1995	NULL
.	NULL

Development	NULL
of	NULL
leukemia	NULL
in	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:1057-1061	NULL
.	NULL

21	NULL
.	NULL

Gunning	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Leavitt	NULL
,	NULL
G.	NULL
Muscat	NULL
,	NULL
S.	NULL
Y.	NULL
Ng	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
human	NULL
B-actin	NULL
expression	NULL
vector	NULL
system	NULL
directs	NULL
high-level	NULL
accumulation	NULL
of	NULL
antisense	NULL
transcripts	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:4831-4835	NULL
.	NULL

22	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
M.	NULL
Hanaoka	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
K.	NULL
I.	NULL
Ki-noshita	NULL
,	NULL
S.	NULL
Shirakawa	NULL
,	NULL
and	NULL
I.	NULL
Miyoshi	NULL
.	NULL

1981	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
antigen	NULL
in	NULL
an	NULL
ATL	NULL
cell	NULL
line	NULL
and	NULL
detection	NULL
of	NULL
antibodies	NULL
to	NULL
the	NULL
antigen	NULL
in	NULL
human	NULL
sera	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:6476-6480	NULL
.	NULL

23	NULL
.	NULL

Iwanaga	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Tsukahara	NULL
,	NULL
T.	NULL
Ohashi	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
M.	NULL
Arai	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
Y.	NULL
Koya	NULL
,	NULL
M.	NULL
Kannagi	NULL
,	NULL
N.	NULL
Yamamoto	NULL
,	NULL
and	NULL
M.	NULL
Fujii	NULL
.	NULL

1999	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
protein	NULL
abrogates	NULL
interleukin-2	NULL
dependence	NULL
in	NULL
a	NULL
mouse	NULL
T-cell	NULL
line	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

73:1271-1277.	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Kiefer	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
M.	NULL
J.	NULL
Braver	NULL
,	NULL
V.	NULL
C.	NULL
Powers	NULL
,	NULL
J.	NULL
J.	NULL
Wu	NULL
,	NULL
S.	NULL
R.	NULL
Umansky	NULL
,	NULL
L.	NULL
D.	NULL
Tomei	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Barr	NULL
.	NULL

1995	NULL
.	NULL

Modulation	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
widely	NULL
distributed	NULL
Bcl-2	NULL
homologue	NULL
Bak	NULL
.	NULL

Nature	NULL
374:736-739	NULL
.	NULL

Kishi	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Saijyo	NULL
,	NULL
M.	NULL
Arai	NULL
,	NULL
S.	NULL
Karasawa	NULL
,	NULL
S.	NULL
Ueda	NULL
,	NULL
M.	NULL
Kannagi	NULL
,	NULL
Y.	NULL
Iwakura	NULL
,	NULL
M.	NULL
Fujii	NULL
,	NULL
and	NULL
S.	NULL
Yonehara	NULL
.	NULL

1997	NULL
.	NULL

Resistance	NULL
to	NULL
fas-mediated	NULL
apoptosis	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
in	NULL
human	NULL
T	NULL
lymphocyte	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-1	NULL
)	NULL
transgenic	NULL
mice	NULL
with	NULL
autoimmune	NULL
arthropathy	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:57-64	NULL
.	NULL

Matsumoto	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Akashi	NULL
,	NULL
H.	NULL
Shibata	NULL
,	NULL
M.	NULL
Yutsudo	NULL
,	NULL
and	NULL
A.	NULL
Hakura	NULL
.	NULL

1994	NULL
.	NULL

Single	NULL
amino	NULL
acid	NULL
substitution	NULL
(	NULL
58Pro-Ser	NULL
)	NULL
in	NULL
HTLV-1	NULL
tax	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
ras	NULL
cooperative	NULL
focus	NULL
formation	NULL
in	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
.	NULL

Virology	NULL
200:813-815	NULL
.	NULL

Matsumoto	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Shibata	NULL
,	NULL
J.	NULL
I	NULL
Fujisawa	NULL
,	NULL
H.	NULL
Inoue	NULL
,	NULL
A.	NULL
Hakura	NULL
,	NULL
T.	NULL
Tsukahara	NULL
,	NULL
and	NULL
M.	NULL
Fujii	NULL
1997	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
via	NULL
two	NULL
distinct	NULL
pathways	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4445-4451	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Z.	NULL
J.	NULL
Liu	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1996	NULL
.	NULL

Selective	NULL
cooperation	NULL
of	NULL
HTLV-1-encoded	NULL
p40'**	NULL
with	NULL
cellular	NULL
oncoproteins	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
hematopoietic	NULL
cell	NULL
proliferation	NULL
.	NULL

Oncogene	NULL
12:2403-2408	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237:1324-1329	NULL
.	NULL

Neuvent	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
G.	NULL
Low	NULL
,	NULL
F.	NULL
Maldarelli	NULL
,	NULL
I.	NULL
Schmitt	NULL
,	NULL
F.	NULL
Majone	NULL
,	NULL
R.	NULL
Gr	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
and	NULL
cell	NULL
cycle	NULL
progression	NULL
:	NULL
role	NULL
of	NULL
cyclin	NULL
D-cdk	NULL
and	NULL
p110Rb	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:3620-3632	NULL
.	NULL

Nicot	NULL
,	NULL
C	NULL
,	NULL
,	NULL
T.	NULL
Astier-Gin	NULL
,	NULL
and	NULL
B.	NULL
Guillemain	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
Bcl-2	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
chronically	NULL
expressing	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I.	NULL
Virology	NULL
236:47-53	NULL
.	NULL

Noel	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
L.	NULL
H.	NULL
Boise	NULL
,	NULL
J.	NULL
M.	NULL
Green	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1996	NULL
.	NULL

CD28	NULL
costimulation	NULL
prevents	NULL
cell	NULL
death	NULL
during	NULL
primary	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:636-642	NULL
.	NULL

Petropoulos	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
I.	NULL
Givol	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Hughes	NULL
.	NULL

1996	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
chicken	NULL
c-myc	NULL
and	NULL
v-myc	NULL
genes	NULL
:	NULL
v-myc	NULL
is	NULL
a	NULL
more	NULL
potent	NULL
inducer	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
apoptosis	NULL
than	NULL
c-myc	NULL
.	NULL

Oncogene	NULL
12:2611-2621	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
H.	NULL
Zha	NULL
,	NULL
C.	NULL
Aime-Sempe	NULL
,	NULL
S.	NULL
Takayama	NULL
,	NULL
and	NULL
H.	NULL
G.	NULL
Wang	NULL
.	NULL

1996	NULL
.	NULL

Structure-function	NULL
analysis	NULL
of	NULL
Bel-2	NULL
family	NULL
proteins	NULL
.	NULL

Regulators	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Adv	NULL
.	NULL

Exp	NULL
.	NULL

Med	NULL
.	NULL

Biol	NULL
.	NULL

406:99-112	NULL
.	NULL

Rosenblatt	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
Miles	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
D.	NULL
Prager	NULL
.	NULL

1995	NULL
.	NULL

Transactivation	NULL
of	NULL
cellular	NULL
genes	NULL
by	NULL
human	NULL
retroviruses	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

193:25-49	NULL
.	NULL

Rosenthal	NULL
,	NULL
N.	NULL
1987	NULL
.	NULL

Identification	NULL
of	NULL
regulatory	NULL
elements	NULL
of	NULL
cloned	NULL
genes	NULL
with	NULL
functional	NULL
assays	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

152:704-720	NULL
.	NULL

Schneider	NULL
,	NULL
U.	NULL
,	NULL
H.	NULL
U.	NULL
Schwenk	NULL
,	NULL
and	NULL
G.	NULL
Borakamm	NULL
.	NULL

1977	NULL
.	NULL

Characterization	NULL
of	NULL
EBV-genome	NULL
negative	NULL
``	NULL
null	NULL
``	NULL
and	NULL
``	NULL
T	NULL
``	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
children	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
leukemic	NULL
transformed	NULL
non-Hodgkin	NULL
lymphoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
19:521-526	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
T.	NULL
Takeda	NULL
,	NULL
A.	NULL
Hikikoshi	NULL
,	NULL
M.	NULL
Sato	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
p40x	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
is	NULL
a	NULL
trans-acting	NULL
activator	NULL
of	NULL
viral	NULL
gene	NULL
transcription	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

76:1127-1131	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-1	NULL
tax	NULL
trans-activator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1875-1885	NULL
.	NULL

(	NULL
Errata	NULL
,	NULL
5:150	NULL
,	NULL
1991	NULL
;	NULL
9:2324	NULL
,	NULL
1995	NULL
.	NULL
)	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Trans-acting	NULL
tran	NULL
INDUCTION	NULL
OF	NULL
Bcl-x	NULL
,	NULL
BY	NULL
HTLV-1	NULL
Tax	NULL
THROUGH	NULL
NF-	NULL
«	NULL
B	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

7987	NULL
scriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
viruses	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Science	NULL
225:381-385	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
activation	NULL
of	NULL
NF-k	NULL
B/Rel	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
Ix	NULL
Bo	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
L	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
trans-activator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:610-614	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
trans-activator	NULL
Tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
binds	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
and	NULL
associates	NULL
with	NULL
enhancer	NULL
DNAs	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
and	NULL
CArG	NULL
box	NULL
.	NULL

Oncogene	NULL
8:2391-2397	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Kitao	NULL
,	NULL
H.	NULL
Matsushime	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1996	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
protein	NULL
interacts	NULL
with	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitor	NULL
p16	NULL
``	NULL
~***	NULL
and	NULL
counteracts	NULL
its	NULL
inhibitory	NULL
activity	NULL
towards	NULL
CDK4	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1607-1614	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Ha-tanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Uhlik	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Good	NULL
,	NULL
G.	NULL
Xiao	NULL
,	NULL
E.	NULL
W.	NULL
Harbaj	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Sun	NULL
.	NULL

1998	NULL
.	NULL

NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
and	NULL
IxB	NULL
kinase	NULL
participate	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
I	NULL
Tax-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
21132-21136	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
J.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNF-	NULL
«	NULL
-induced	NULL
apoptosis	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
274:787-789	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

TNF-	NULL
and	NULL
cancer	NULL
therapy-induced	NULL
apoptosis	NULL
:	NULL
potentiation	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
274:784-787	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
M.	NULL
W.	NULL
Mayo	NULL
,	NULL
R.	NULL
G.	NULL
Korneluk	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1998	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
antiapoptosis	NULL
:	NULL
induction	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
and	NULL
c-IAP1	NULL
and	NULL
c-IAP2	NULL
to	NULL
suppress	NULL
caspase-8	NULL
activation	NULL
.	NULL

Science	NULL
281:1680-1683	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Lee	NULL
,	NULL
R.	NULL
E.	NULL
Bellas	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
M.	NULL
J.	NULL
FitzGerald	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
D.	NULL
H.	NULL
Sherr	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-xB/Rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4682-4690	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
X.	NULL
,	NULL
Z.	NULL
Ao	NULL
,	NULL
K.	NULL
V.	NULL
Prasad	NULL
,	NULL
R.	NULL
Wu	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Schlossman	NULL
.	NULL

1998	NULL
.	NULL

IEX-1L	NULL
,	NULL
an	NULL
apoptosis	NULL
inhibitor	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B-mediated	NULL
cell	NULL
survival	NULL
.	NULL

Science	NULL
281:998-1001	NULL
.	NULL

Yamada	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Goto	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
Y.	NULL
Tsujimoto	NULL
,	NULL
and	NULL
M.	NULL
Ha-tanaka	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
induces	NULL
apoptosis	NULL
which	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
Bel-2	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3374-3379.	NULL
.	NULL

Yin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
B.	NULL
Christerson	NULL
,	NULL
Y.	NULL
Yamamoto	NULL
,	NULL
Y.	NULL
T.	NULL
Kwak	NULL
,	NULL
S.	NULL
Xu	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
H.	NULL
Cobb	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1998	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
protein	NULL
binds	NULL
to	NULL
MEKK1	NULL
to	NULL
stimulate	NULL
IxB	NULL
kinase	NULL
activity	NULL
and	NULL
NF-kB	NULL
activation	NULL
.	NULL

Cell	NULL
93:875-884	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
H.	NULL
Hirai	NULL
.	NULL

1995	NULL
.	NULL

HTLV-1	NULL
oncoprotein	NULL
tax	NULL
and	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

193:79-89	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
Z.	NULL
Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

